Advances in the treatment of thrombotic thrombocytopenic purpura: repurposed drugs and novel agents-Reference-Cited by-同舟云学术

Advances in the treatment of thrombotic thrombocytopenic purpura: repurposed drugs and novel agents

Published:2020-04-10 Issue:5 Volume:13 Page:461-470
ISSN:1747-4086
Container-title:Expert Review of Hematology
language:en
Short-container-title:Expert Review of Hematology

Author:

Gómez-De León Andrés¹,Villela-Martínez Luis Mario²³,Yáñez-Reyes José Miguel¹,Gómez-Almaguer David¹^ORCID

Affiliation:

1. Hematology Department, Universidad Autónoma de Nuevo León, Facultad de Medicina y Hospital Universitario ‘Dr. José Eleuterio González’, Monterrey, México

2. Centro Médico “Dr. Ignacio Chavez”. ISSSTESON, Hermosillo, México

3. Universidad del Valle de México. Campus Hermosillo, Hermosillo, México

Publisher

Informa UK Limited

Subject

Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/17474086.2020.1750361

Reference106 articles.

1. Consensus on the standardization of terminology in thrombotic thrombocytopenic purpura and related thrombotic microangiopathies

2. Pathophysiology of thrombotic thrombocytopenic purpura

3. Pathogenicity of Anti-ADAMTS13 Autoantibodies in Acquired Thrombotic Thrombocytopenic Purpura

4. Concentration and Subclass Distribution of Anti-ADAMTS13 IgG Autoantibodies in Different Stages of Acquired Idiopathic Thrombotic Thrombocytopenic Purpura

5. Additional autoimmune disorders in patients with acquired autoimmune thrombotic thrombocytopenic purpura

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune thrombotic thrombocytopenic purpura: clinical suspicion and basic management in emergency departments — an expert review and consensus statement from the Spanish societies of hematology and hemotherapy (SEHH) and emergency medicine (SEMES);Emergencias;2024-07-02

2. Atypical Presentations of Pediatric-Acquired Thrombotic Thrombocytopenic Purpura;Journal of Pediatric Hematology/Oncology;2024-06-27

3. Hemostatic Profile and Serological Response of Patients with Immune Thrombotic Thrombocytopenic Purpura after Receiving BNT162b2 Vaccine: A Prospective Study;Thrombosis and Haemostasis;2023-05-12

4. Combination regimens containing daratumumab for initial diagnosed acquired thrombotic thrombocytopenic purpura;Journal of Thrombosis and Thrombolysis;2023-01-13

5. The utility of platelet activation biomarkers in thrombotic microangiopathies;Platelets;2022-03-15